- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo "GeparDouze"
This study looks at new ways to treat early triple-negative breast cancer. It combines standard chemotherapy with a newer drug, Atezolizumab (or a dummy drug), to see if it can stop the cancer from coming back. It's a large study, comparing different treatment approaches.
For: Patients with early breast cancerGermany · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
A phase II trial to assess the activity and tolerability of Thymosin alpha 1 in Cystic Fibrosis Patients
This study is looking at a new treatment called Thymosin alpha 1 (brand name ZADAXIN®) for cystic fibrosis. It wants to see if this treatment can reduce inflammation in the lungs and if it's safe for patients. Researchers will check levels of inflammation markers in sputum and monitor overall health.
For: Cystic FibrosisItaly